Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
300 participants
INTERVENTIONAL
2024-07-02
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pitocin or Oral Misoprostol for PROM IOL
NCT04028765
Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon
NCT01139801
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
NCT04478942
A Study Comparing Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor
NCT01634854
Labor Induction With a Combined Method (Pharmacologic and Mechanical): Randomized Controlled Trial
NCT03928600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Misoprostol and Pitocin
Patient receives misoprostol and foley catheter for initial induction of labor, followed by pitocin later on.
Misoprostol
25 mcg vaginally every 6 hours
Pitocin
3-6 mL intravenously every hour
Pitocin only
Patient receives pitocin and foley catheter for initial induction of labor, followed by more pitocin later on.
Pitocin
3-6 mL intravenously every hour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
25 mcg vaginally every 6 hours
Pitocin
3-6 mL intravenously every hour
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bronx Care Health System
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Angela Bianco
Division Director, MFM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicola F Tavella, MPH
Role: STUDY_DIRECTOR
Icahn School of Medicine at Mount Sinai
Angela Bianco, MD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Sinai Hospital
New York, New York, United States
Bronx Care Health System
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-24-00118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.